well done #NatcoPharma
They have launched Baricitinib in India at Rs. 30 a dose, whereas the imported ones cost 3000
why well done? Because they have launched it "AT RISK" . The patent holder can sue and take them to the cleaners
They have launched Baricitinib in India at Rs. 30 a dose, whereas the imported ones cost 3000
why well done? Because they have launched it "AT RISK" . The patent holder can sue and take them to the cleaners
They #NatcoPharma do not have any guarantee for the Govt of India under compulsory licensing
But, they have taken the huge risk in the interest of the country.
The patent waiver may come or not, They have gone ahead with it
But, they have taken the huge risk in the interest of the country.
The patent waiver may come or not, They have gone ahead with it
The Indian pharma industry has certainly risen to the occasion, much beyond the call of duty.
This needs to be told, because they receive a lot of flak on even small things
This needs to be told, because they receive a lot of flak on even small things
Only those who know about the pharma industry and how it functions on Patents can guage the risk which #Natcopharma has undertaken
and people talk of Pfizer and JJ, which want sovereign guarantees against problems with their vaccines
Natco Pharma launches Baricitinib in India without patent waiver approval medicaldialogues.in/news/industry/…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
